97 related articles for article (PubMed ID: 7992082)
1. Influence of isotope dose on somatostatin receptor imaging: when less is better.
Schirmer TP; O'Dorisio TM; Olsen JO; Hinkle GH; O'Dorisio MS; Schirmer WJ
Semin Oncol; 1994 Oct; 21(5 Suppl 13):51-5. PubMed ID: 7992082
[No Abstract] [Full Text] [Related]
2. Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy.
Wiedenmann B; Bäder HM; Scherubl H; Fett U; Zimmer T; Hamm B; Koppenhagen K; Riecken EO
Semin Oncol; 1994 Oct; 21(5 Suppl 13):29-32. PubMed ID: 7992077
[No Abstract] [Full Text] [Related]
3. Localization of gastroenteropancreatic neuroendocrine tumors with 111indium-pentetreotide scintigraphy.
Pauwels S; Leners N; Fiasse R; Jamar F
Semin Oncol; 1994 Oct; 21(5 Suppl 13):15-20. PubMed ID: 7992075
[No Abstract] [Full Text] [Related]
4. Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with (68)Ga-DOTATOC PET.
Henze M; Schuhmacher J; Dimitrakopoulou-Strauss A; Strauss LG; Mäcke HR; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2004 Mar; 31(3):466. PubMed ID: 14730407
[No Abstract] [Full Text] [Related]
5. Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.
Forssell-Aronsson E; Fjälling M; Nilsson O; Tisell LE; Wängberg B; Ahlman H
J Nucl Med; 1995 Jan; 36(1):7-12. PubMed ID: 7799086
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.
Ahlman H; Tisell LE; Wängberg B; Nilsson O; Forssell-Aronsson E; Fjälling M
Semin Oncol; 1994 Oct; 21(5 Suppl 13):21-8. PubMed ID: 7992076
[No Abstract] [Full Text] [Related]
7. [The scintigraphy of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
Chiti A; Spinelli A; Bombardieri E
Radiol Med; 1997 Oct; 94(4):362-70. PubMed ID: 9465244
[No Abstract] [Full Text] [Related]
8. [A new diagnostic method: somatostatin receptor scintigraphy of neuroendocrine tumors].
Westlin JE; Janson ET; Ahlström H; Ohrvall U; Arnberg H; Nilsson S; Akerström G; Oberg K
Lakartidningen; 1992 Dec; 89(50):4377-9. PubMed ID: 1469974
[No Abstract] [Full Text] [Related]
9. Metastasis of neuroendocrine colon carcinoma mimicking Graves' ophthalmopathy.
Busse F; Führer D; Stumvoll M; Schneider JP; Neid M; Kluge R; Sterker I
Thyroid; 2008 Nov; 18(11):1237-8. PubMed ID: 18925841
[No Abstract] [Full Text] [Related]
10. Masking effect of chronic pancreatitis in the interpretation of somatostatin receptor positron emission tomography in pancreatic neuroendocrine tumors.
Treglia G; Farchione A; Stefanelli A; Brizi MG; Larghi A; Inzani F; Rindi G; Rufini V
Pancreas; 2013 May; 42(4):726-8. PubMed ID: 23591437
[No Abstract] [Full Text] [Related]
11. Biodistribution of 111In-pentetreotide and dosimetric considerations with respect to somatostatin receptor expressing tumor burden.
Adrian HJ; Dörr U; Bach D; Bihl H
Horm Metab Res Suppl; 1993; 27():18-23. PubMed ID: 8330868
[TBL] [Abstract][Full Text] [Related]
12. [The role of echoendoscopy and scintigraphy of somatostatin receptors in the staging of neuro-endocrine digestive tumors].
Giovannini M; Pasquier J; Brenot-Rossi I; Perrier H; Sauvan R; Seitz JF
Ann Gastroenterol Hepatol (Paris); 1995; 31(2):109-13. PubMed ID: 7618832
[No Abstract] [Full Text] [Related]
13. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
Lamberts SW; Hofland LJ; van Koetsveld PM; Reubi JC; Bruining HA; Bakker WH; Krenning EP
J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-EDDA/HYNIC-TOC somatostatin receptor scintigraphy in daily clinical practice.
Chrapko BE; Nocuń A; Gołebiewska R; Stefaniak B; Korobowicz E; Czekajska-Chehab E; Sawicki M; Polkowski WP
Med Sci Monit; 2010 Apr; 16(4):MT35-44. PubMed ID: 20357727
[TBL] [Abstract][Full Text] [Related]
15. Therapy with radiolabeled somatostatin peptide analogs for metastatic neuroendocrine tumors.
Bushnell D
J Gastrointest Surg; 2006 Mar; 10(3):335-6. PubMed ID: 16622984
[No Abstract] [Full Text] [Related]
16. Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide.
Nocaudie-Calzada M; Huglo D; Deveaux M; Carnaille B; Proye C; Marchandise X
J Nucl Med; 1994 Jan; 35(1):57-62. PubMed ID: 8271061
[TBL] [Abstract][Full Text] [Related]
17. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
[TBL] [Abstract][Full Text] [Related]
18. [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system].
Faiss S; Scherübl H; Bäder M; Fett U; Koppenhagen K; Wiedenmann B; Riecken EO
Z Gastroenterol; 1994 May; 32(5):243-6. PubMed ID: 7915450
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin-receptor imaging in the localization of endocrine tumors.
Lamberts SW; Bakker WH; Reubi JC; Krenning EP
N Engl J Med; 1990 Nov; 323(18):1246-9. PubMed ID: 2170840
[TBL] [Abstract][Full Text] [Related]
20. False-positive In-111 DTPA octreotide scintigraphy resulting from lung abscess in a patient with metastatic neuroendocrine pancreatic neoplasm.
Valero M; Boán JF; Rodriguez-Spiteri N; Torre W; Richter JA
Clin Nucl Med; 2006 Jan; 31(1):20-2. PubMed ID: 16374117
[No Abstract] [Full Text] [Related]
[Next] [New Search]
